Sponsor Dossier
Reach Pharmaceuticals
Sponsor Dossier for Reach Pharmaceuticals. ARTG portfolio, PBS-listed brands, PBAC activity, AusPAR record — compiled by arcimedes.
- Brand: CAPTOPRIL
- Brand: CARBOPROST-REACH
- Brand: CYCLOPHOSPHAMIDE-REACH
- Brand: DEXRAZOXANE-REACH
- Brand: FOSAPREPITANT
- Brand: FUROSEMIDE-REACH
- Brand: METABOLICS
- Brand: MSN
About
Reach Pharmaceuticals is an Australian Private Company with ABN 25 623 897 183, registered in Victoria. The company is active and registered for GST from 1 July 2020.
Portfolio
Reach Pharmaceuticals has 11 brands on the ARTG, of which 10 are indexable. Nine brands have Product Information on file. One brand has at least one PBS-listed item, and one brand has PBAC outcome records. Two brands have AusPAR records.
Therapeutic focus
— Oncology: 7 brands — Cardiology: 2 brands — Women's Health: 1 brand — Complementary Medicine: 1 brand
PBS footprint
One brand in the Reach Pharmaceuticals portfolio is PBS-listed. The latest PBS schedule date the portfolio touched was 1 May 2026.
Regulatory activity
The latest PBAC outcome for Reach Pharmaceuticals is from 1 November 2016, covering one brand. The latest AusPAR is dated 20 March 2025, with two brands holding AusPAR records on file.